Cholangiocarcinoma

The AJMC® Cholangiocarcinoma compendium is a comprehensive resource for clinical news and expert insights about this rare cancer of the bile duct.

Latest News

Postoperative TACE Prolongs RFS in Patients With Combined Hepatocellular-Cholangiocarcinoma
Postoperative TACE Prolongs RFS in Patients With Combined Hepatocellular-Cholangiocarcinoma

December 19th 2022

Overall survival for patients with combined hepatocellular-cholangiocarcinoma is poor, but those who received adjuvant transarterial chemoembolization (TACE) after surgery had a prolonged recurrence-free survival (RFS).

Case Report Details Diagnostic Imaging for Rare Distal Cholangiocarcinoma Case
Case Report Details Diagnostic Imaging for Rare Distal Cholangiocarcinoma Case

December 15th 2022

Surveillance Program Ineffective at Detecting Cholangiocarcinoma Early Enough for Benefit in Patients With PSC
Surveillance Program Ineffective at Detecting Cholangiocarcinoma Early Enough for Benefit in Patients With PSC

November 30th 2022

Study: FGFR mRNA Overexpression Occurs Frequently for Those With Cholangiocarcinoma
Study: FGFR mRNA Overexpression Occurs Frequently for Those With Cholangiocarcinoma

November 29th 2022

FGFR Inhibitors Show Promise in Cholangiocarcinoma but Face Acquired Resistance
FGFR Inhibitors Show Promise in Cholangiocarcinoma but Face Acquired Resistance

November 25th 2022

Video Interviews
Podcasts

More News

© 2023 MJH Life Sciences
AJMC®
All rights reserved.